XBiotech: Jumps after co identifies antibodies for potential COVID-19 therapy

XBiotech

17/08/2020 13:44

** Drug developer's shares  XBIT.O  rise 24.5% to $21.45
premarket - set to erase YTD losses if gains hold 
    ** Co says it has identified antibodies from donor blood
that could potentially be used as a therapy for the novel
coronavirus  urn:newsml:reuters.com:*:nGNE77qfXx
    ** Antibodies were discovered through a collaboration with
BioBridge Global and QualTex Laboratories 
    **  XBiotech says it selected blood samples from patients
who had recovered rapidly from the virus without serious illness
    ** XBIT said in April it would collaborate with BioBridge
Global for identifying antibodies  urn:newsml:reuters.com:*:nL4N2BU2IJ


 (Reporting by Manas Mishra in Bengaluru)
 ((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780,
outside U.S. +91 806749 2709;))